Bosch Alessandra, Albisetti Manuela, Goldenberg Neil A, Van Ommen Heleen C, Rizzi Mattia
Department of Hematology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Institute for Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA; Department of Pediatrics and Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
J Thromb Haemost. 2025 Mar;23(3):1107-1116. doi: 10.1016/j.jtha.2024.12.009. Epub 2024 Dec 20.
Arterial thrombosis is increasingly recognized in children and is most commonly related to the presence of an arterial catheter. Diagnosis and treatment of arterial thrombosis in children varies widely and consists of commonly available anticoagulants and antiplatelet drugs. No evidence-based guidelines exist for management strategies for catheter-related arterial thrombosis (CAT).
To understand pediatric hematologists' current practices and opinions in the management of CAT in children and neonates.
A multinational survey on diagnostic and management practices from experts and practitioners in the field was conducted by means of a questionnaire with general questions and specific clinical CAT scenarios in regard to umbilical arterial catheters, extremity indwelling arterial catheters, and cardiac catheterization.
Of 54 complete survey responses, there was agreement that Doppler ultrasound is the preferred diagnostic modality to identify CAT and unfractionated heparin and low-molecular-weight heparin are the preferred antithrombotic treatments, while thrombolysis/thrombectomy is used in life-/limb-threatening CAT, long-term follow-up is necessary to detect adverse outcomes, and generally no thrombophilia testing is indicated. There was considerable heterogeneity in treatment indications on when to start antithrombotic treatment, treatment duration, timepoint of catheter removal, and length of follow-up.
These results highlight some congruency, but also considerable heterogeneity, in the management practices of CAT. Based on these findings, an international guidance document is necessary to harmonize management practices and further clinical investigations of CAT.
动脉血栓形成在儿童中越来越受到重视,最常见于存在动脉导管的情况。儿童动脉血栓形成的诊断和治疗差异很大,包括常用的抗凝剂和抗血小板药物。目前尚无关于导管相关动脉血栓形成(CAT)管理策略的循证指南。
了解儿科血液科医生在儿童和新生儿CAT管理方面的当前实践和观点。
通过一份包含一般问题以及关于脐动脉导管、肢体留置动脉导管和心导管插入术等特定临床CAT场景的问卷,对该领域的专家和从业者进行了一项关于诊断和管理实践的跨国调查。
在54份完整的调查回复中,大家一致认为,多普勒超声是识别CAT的首选诊断方式,普通肝素和低分子肝素是首选的抗栓治疗药物,而在危及生命/肢体的CAT中使用溶栓/血栓切除术,需要进行长期随访以检测不良后果,并且一般不建议进行血栓形成倾向检测。在何时开始抗栓治疗、治疗持续时间、导管拔除时间点以及随访时长等治疗指征方面存在相当大的异质性。
这些结果凸显了CAT管理实践中的一些一致性,但也存在相当大的异质性。基于这些发现,有必要制定一份国际指导文件,以统一CAT的管理实践并进一步开展临床研究。